Diaverum

Sector Healthcare
Location Stockholm
Date acquired 2007
Transaction size Not disclosed

Diaverum is a leading global provider of life enhancing renal care to patients with Chronic Kidney Disease 


The company operates in a sizeable and growing market with robust industry fundamentals, where the number of patients requiring kidney care is growing due to changes in the population dynamics and lifestyles.

To learn more about the company, click here.

With over 11,000 employees worldwide, caring for circa. 39,000 patients, offering 6 million treatments annually and running more than 421 clinics in 22 countries.

Headquartered in Sweden, Diaverum’s main focus is on haemodialysis, in conjunction with a portfolio of treatments ranging from preventive care, peritoneal dialysis and home care to co-ordination of patients’ comorbidities and transplantation services. Chronic Kidney Disease is seen as a global and escalating challenge today affecting about 10% of the world’s adult population. It’s primarily caused by lifestyle diseases such as diabetes, and the prevalence is increasing in particular in developing countries.

We use strictly necessary cookies to make our site work. Currently the analytics cookies which allow us to collect information about how visitors use our website and help us to improve it; is defaulted to ‘InActive’, if you wish to turn this on you can do so through the Cookie Settings. Please be aware that by blocking some types of cookies it may impact your experience of the site and the services we are able to offer. For more information about any of these cookies and our use of them, or to change your settings at any time, please see Cookie Settings and Cookies Policy.